BREAST CANCER PANEL 2

ER & PR receptor assays are routinely performed on Breast carcinomas to assess responsiveness to endocrine therapy and prognosis. Cathepsin D positivity is a poor prognostic sign.

  • Test Type:
  • Pre-test Information:
    No special preparation required
  • Report Delivery:
    Sample Daily by 6 pm Report5 days: Blocks / Sections / Smears 7 days: Tissue
  • Components:
    0

Sample Report